Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02090127
Title Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Recruitment No longer available
Gender female
Phase Phase I
Variant Requirements No
Sponsors AVEO Pharmaceuticals, Inc.
Indications
Therapies

Ficlatuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.